Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.01 -0.14 (-3.37%)
At close: Sep 30, 2026 · 4:00 PM EDT

Adial Pharmaceuticals (ADIL) Short term Debt (2018)

Updated

Adial Pharmaceuticals (ADIL) recorded Short term Debt of $138,603 in Q3 2018, up 383.3% from the prior quarter.

Analysis

Adial Pharmaceuticals (ADIL) Short term Debt (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Adial Pharmaceuticals 19.18 Mn 19.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 138,603.00
Jun 30, 2018 28,676.00
API Access

Adial Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=ADIL&period=max&api_key=YOUR_API_KEY